1
|
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.
|
Lancet Oncol
|
2005
|
9.67
|
2
|
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.
|
Int J Cancer
|
2004
|
4.10
|
3
|
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
|
Lancet Oncol
|
2011
|
3.98
|
4
|
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
|
BMJ
|
2010
|
3.41
|
5
|
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
|
Vaccine
|
2006
|
2.78
|
6
|
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
|
Vaccine
|
2007
|
2.64
|
7
|
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
|
Cancer Prev Res (Phila)
|
2009
|
2.42
|
8
|
Seroepidemiology of the human polyomaviruses.
|
J Gen Virol
|
2003
|
2.32
|
9
|
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
|
PLoS Med
|
2006
|
2.10
|
10
|
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
|
Vaccine
|
2008
|
2.09
|
11
|
The effects of storage time and sampling season on the stability of serum 25-hydroxy vitamin D and androstenedione.
|
Nutr Cancer
|
2010
|
1.86
|
12
|
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
|
Gynecol Oncol
|
2012
|
1.70
|
13
|
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
|
Hum Vaccin
|
2009
|
1.66
|
14
|
Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.
|
J Adolesc Health
|
2007
|
1.63
|
15
|
Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
|
Am J Epidemiol
|
2008
|
1.62
|
16
|
Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland.
|
J Adolesc Health
|
2007
|
1.60
|
17
|
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
|
Acta Oncol
|
2007
|
1.51
|
18
|
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
|
Int J Cancer
|
2002
|
1.43
|
19
|
Proximity of first sexual intercourse to menarche and risk of high-grade cervical disease.
|
J Infect Dis
|
2012
|
1.39
|
20
|
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
|
J Gen Virol
|
2003
|
1.20
|
21
|
Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
|
J Gen Virol
|
2005
|
1.15
|
22
|
Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years.
|
J Adolesc Health
|
2009
|
1.15
|
23
|
Introducing human papillomavirus vaccines - questions remain.
|
Ann Med
|
2008
|
1.14
|
24
|
High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
|
Int J Cancer
|
2004
|
1.12
|
25
|
Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.
|
Int J Cancer
|
2009
|
1.11
|
26
|
Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish females.
|
Int J Behav Nutr Phys Act
|
2009
|
1.09
|
27
|
Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women.
|
Int J Cancer
|
2011
|
1.08
|
28
|
Understanding long-term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry-based follow-up.
|
Int J Cancer
|
2012
|
1.04
|
29
|
Determinants of maternal sex steroids during the first half of pregnancy.
|
Obstet Gynecol
|
2011
|
1.01
|
30
|
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination.
|
Int J Cancer
|
2012
|
1.01
|
31
|
Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer.
|
Int J Cancer
|
2011
|
1.00
|
32
|
Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33.
|
Int J Cancer
|
2010
|
1.00
|
33
|
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
|
J Infect Dis
|
2013
|
1.00
|
34
|
Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.99
|
35
|
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
|
Scand J Infect Dis
|
2008
|
0.98
|
36
|
Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study.
|
Eur J Cancer
|
2010
|
0.95
|
37
|
Cervical cancer incidence can increase despite HPV vaccination.
|
Lancet Infect Dis
|
2010
|
0.94
|
38
|
Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.93
|
39
|
Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.
|
Am J Obstet Gynecol
|
2003
|
0.93
|
40
|
Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.
|
Acta Oncol
|
2007
|
0.93
|
41
|
Chlamydial antibodies and risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.92
|
42
|
Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
|
Int J Cancer
|
2002
|
0.90
|
43
|
Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes.
|
Scand J Infect Dis
|
2010
|
0.90
|
44
|
In vivo and in vitro intragenomic rearrangement of TT viruses.
|
J Virol
|
2007
|
0.90
|
45
|
Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure.
|
Cancer Causes Control
|
2008
|
0.90
|
46
|
Serum 25-hydroxyvitamin D at pregnancy and risk of breast cancer in a prospective study.
|
Eur J Cancer
|
2010
|
0.89
|
47
|
Chlamydial heat shock protein 60--specific T cells in inflamed salpingeal tissue.
|
Fertil Steril
|
2002
|
0.89
|
48
|
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: a nested case-referent study.
|
Int J Cancer
|
2009
|
0.88
|
49
|
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring: a nested case-control study.
|
APMIS
|
2008
|
0.88
|
50
|
Chlamydia pneumoniae infection and the risk of female early-onset lung cancer.
|
Int J Cancer
|
2003
|
0.88
|
51
|
Human chorionic gonadotropin in pregnancy and maternal risk of breast cancer.
|
Cancer Res
|
2010
|
0.86
|
52
|
A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003.
|
BMC Infect Dis
|
2008
|
0.86
|
53
|
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
|
Am J Epidemiol
|
2006
|
0.86
|
54
|
High prevalence of HPV among female students in Finland.
|
Scand J Infect Dis
|
2005
|
0.86
|
55
|
Just implementation of human papillomavirus vaccination.
|
J Med Ethics
|
2011
|
0.85
|
56
|
Lack of association between human papillomavirus type 16 and 18 infections and female lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.85
|
57
|
Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
|
Eur J Cancer
|
2009
|
0.83
|
58
|
Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
|
Int J Cancer
|
2013
|
0.82
|
59
|
Circulating sex steroids during pregnancy and maternal risk of non-epithelial ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.82
|
60
|
The ethics of implementing human papillomavirus vaccination in developed countries.
|
Med Health Care Philos
|
2011
|
0.82
|
61
|
Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women.
|
Scand J Infect Dis
|
2010
|
0.82
|
62
|
Phylogenetically diverse TT virus viremia among pregnant women.
|
Virology
|
2012
|
0.82
|
63
|
Cost effectiveness of prophylactic HPV 16/18 vaccination in Finland: results from a modelling exercise.
|
J Med Econ
|
2010
|
0.82
|
64
|
Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.
|
PLoS One
|
2013
|
0.81
|
65
|
Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.
|
Infect Dis Obstet Gynecol
|
2011
|
0.81
|
66
|
Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis.
|
Eur J Cancer
|
2009
|
0.81
|
67
|
Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study.
|
Int J Cancer
|
2013
|
0.81
|
68
|
Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand.
|
Asian Pac J Cancer Prev
|
2014
|
0.81
|
69
|
Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence.
|
BMC Res Notes
|
2011
|
0.80
|
70
|
Impact of HPV vaccination on young women's quality of life - a five year follow-up study.
|
Eur J Contracept Reprod Health Care
|
2010
|
0.80
|
71
|
No risk of maternal EBV infection for childhood leukemia.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.79
|
72
|
Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women.
|
Int J Cancer
|
2009
|
0.79
|
73
|
Maternal human polyomavirus infection and risk of neuroblastoma in the child.
|
Int J Cancer
|
2005
|
0.79
|
74
|
Impact of HPV16/18 vaccination on quality of life: a pilot study.
|
Eur J Contracept Reprod Health Care
|
2013
|
0.78
|
75
|
The burden and costs of prevention and management of genital disease caused by HPV in women: a population-based registry study in Finland.
|
Int J Cancer
|
2013
|
0.78
|
76
|
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.
|
Emerg Infect Dis
|
2016
|
0.78
|
77
|
LINDA - a solution-focused low-intensity intervention aimed at improving health behaviors of young females: a cluster-randomized controlled trial.
|
BMC Public Health
|
2013
|
0.77
|
78
|
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: joint effect with vitamin D?
|
Eur J Cancer
|
2010
|
0.77
|
79
|
Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses.
|
Future Oncol
|
2010
|
0.77
|
80
|
Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.76
|
81
|
Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancy.
|
Cancer Causes Control
|
2011
|
0.76
|
82
|
Impact of human papillomavirus vaccination depends on effective vaccination strategy.
|
Int J Cancer
|
2009
|
0.76
|
83
|
Women and vaccinations: From smallpox to the future, a tribute to a partnership benefiting humanity for over 200 years.
|
Hum Vaccin
|
2009
|
0.76
|
84
|
Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study.
|
BMC Res Notes
|
2014
|
0.75
|
85
|
Prophylactic human papillomavirus vaccine.
|
Womens Health (Lond Engl)
|
2006
|
0.75
|
86
|
Geographic distribution of cervical cancer-associated human leucocyte antigens and cervical cancer incidence in Finland.
|
Int J STD AIDS
|
2007
|
0.75
|
87
|
First-generation vaccines against human papillomavirus.
|
Womens Health (Lond Engl)
|
2005
|
0.75
|
88
|
Preventing common sexually transmitted infections in adolescents: time for rethinking.
|
Eur J Contracept Reprod Health Care
|
2006
|
0.75
|
89
|
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
|
Acta Obstet Gynecol Scand
|
2008
|
0.75
|
90
|
An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnoses.
|
Sex Transm Dis
|
2012
|
0.75
|
91
|
Population-Based Study of Prediagnostic Antibodies to Chlamydia trachomatis in Relation to Adverse Pregnancy Outcome.
|
Sex Transm Dis
|
2016
|
0.75
|
92
|
Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.
|
Cancer Causes Control
|
2011
|
0.75
|
93
|
Changes over time in the Chlamydia trachomatis serotype distribution in Finnish women.
|
Scand J Infect Dis
|
2014
|
0.75
|
94
|
[Not Available].
|
Duodecim
|
2006
|
0.75
|